ZJYL vs. KIDS, DCTH, CLPT, SMLR, NNOX, TCMD, NPCE, ZIMV, CVRX, and NYXH
Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include OrthoPediatrics (KIDS), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), NeuroPace (NPCE), ZimVie (ZIMV), CVRx (CVRX), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry.
Jin Medical International vs.
OrthoPediatrics (NASDAQ:KIDS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, community ranking, institutional ownership, valuation, earnings, risk, profitability and dividends.
Jin Medical International has lower revenue, but higher earnings than OrthoPediatrics.
OrthoPediatrics currently has a consensus price target of $39.00, suggesting a potential upside of 64.14%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, equities research analysts plainly believe OrthoPediatrics is more favorable than Jin Medical International.
OrthoPediatrics received 311 more outperform votes than Jin Medical International when rated by MarketBeat users.
OrthoPediatrics has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 13.47, indicating that its share price is 1,247% more volatile than the S&P 500.
In the previous week, OrthoPediatrics had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for OrthoPediatrics and 0 mentions for Jin Medical International. OrthoPediatrics' average media sentiment score of 0.95 beat Jin Medical International's score of 0.00 indicating that OrthoPediatrics is being referred to more favorably in the media.
Jin Medical International has a net margin of 0.00% compared to OrthoPediatrics' net margin of -15.00%. Jin Medical International's return on equity of 0.00% beat OrthoPediatrics' return on equity.
69.1% of OrthoPediatrics shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
OrthoPediatrics beats Jin Medical International on 9 of the 15 factors compared between the two stocks.
Get Jin Medical International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jin Medical International Competitors List
Related Companies and Tools
This page (NASDAQ:ZJYL) was last updated on 2/22/2025 by MarketBeat.com Staff
Free ZJYL Stock Alerts